Envoy Medical, Inc. (COCH)
NASDAQ · Healthcare
Envoy Medical, Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 241,000 | 225,000 | 316,000 | 237,000 |
| Gross Profit | -633,000 | -517,000 | -473,000 | -261,000 |
| Profitability | ||||
| Operating Income | -22.3M | -19.3M | -18.4M | -8.7M |
| EBITDA | — | — | — | — |
| Net Income | -23.8M | -20.8M | -29.9M | -15.9M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 23M | 19M | 12M | 10M |
Envoy Medical, Inc. Income Statement — FAQ
Envoy Medical, Inc. (COCH) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COCH's income statement history?
The chart and table above show Envoy Medical, Inc.'s income statement by year and by quarter, including the growth rate.